ClinConnect ClinConnect Logo
Search / Trial NCT06714747

Soft Tissue Prediction in Orthognathic Surgery by Making Anatomically Accurate Virtual Model

Launched by IRCCS AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA · Dec 2, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how to create accurate virtual models of the face to help plan orthognathic surgery, which is a procedure used to correct jaw and facial bone issues. The goal of this surgery is to improve both the function of the jaw and the appearance of the face. By using detailed imaging techniques like cone beam computed tomography (CBCT) and MRI, the surgeons hope to better understand how changes in the bones will affect the surrounding soft tissues, leading to more successful outcomes for patients.

To participate in the trial, individuals must be at least 18 years old and scheduled for orthognathic surgery. They also need to have certain imaging studies done before the surgery. However, people with specific conditions, such as cleft lip or facial syndromes, or those who have had certain cosmetic procedures, will not be eligible. Participants can expect to undergo careful planning and monitoring throughout the process to ensure the best possible results from their surgery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients undergoing orthognathic surgery and preoperative radiographic study with CBCT and MRI
  • Patients with age \> or = 18 years old
  • Obtaining informed consent
  • Patients with preoperative teleradiography and orthopantomography
  • Exclusion Criteria:
  • patients with cleft lip-palate, facial malformations and/or syndromes (syndromes with involvement of the cephalic extremity, such as sd of Apert. Cropuzon, Ofeiffer, Treacher Collins)
  • patients who have undergone application of Medpor prostheses or who have undergone ancillary procedures (lipofilling, fillers, volumetric facial augmentations with insertion of polyethylene ketone prostheses)

About Irccs Azienda Ospedaliero Universitaria Di Bologna

IRCCS Azienda Ospedaliero-Universitaria di Bologna is a prestigious research and healthcare institution in Italy, renowned for its commitment to advancing medical science and patient care through innovative clinical research. As an IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), it integrates clinical practice with scientific research, facilitating the translation of laboratory findings into effective treatment strategies. The institution fosters a multidisciplinary approach, collaborating with various experts to conduct high-quality clinical trials aimed at improving health outcomes across a wide range of medical fields. With a strong emphasis on ethical standards and patient welfare, IRCCS Azienda Ospedaliero-Universitaria di Bologna plays a vital role in shaping the future of medicine through rigorous scientific inquiry and patient-centered care.

Locations

Bologna, Emilia Romagna, Italy

Patients applied

0 patients applied

Trial Officials

Claudio Marchetti, MD

Principal Investigator

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported